Potential Anti-osteoporosis compounds from Zingiber officinale: A Molecular Docking and Pharmacokinetics Prediction

• Main Authors: Maria Apriliani Gani, -, Ahmad Dzulfikri Nurhan, -, Fedik Abdul Rantam, -, Chrismawan Ardianto, -, Junaidi Khotib, -
• Format: Article PeerReviewed
• Language: English; English; English
• Published: A and V Publication 2022
• Subjects: R Medicine; RS Pharmacy and materia medica; RS1-441 Pharmacy and materia medica; RS200-201 Pharmaceutical dosage forms
• Online Access: https://repository.unair.ac.id/125198/1/Artikel%20C-19.pdf; https://repository.unair.ac.id/125198/3/%28C-19%29%20Kualitas%20Karil.pdf; https://repository.unair.ac.id/125198/2/Similarity%20C-19.pdf; https://repository.unair.ac.id/125198/; https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-12-42; https://doi.org/10.52711/0974-360X.2022.00948
• Institution: Universitas Airlangga

Osteoporosis is a systemic skeletal disease characterized by low bone mass, that can result in fracture when injury, for example, due to a traffic accident. This study aimed to identify secondary metabolites from Zingiber officinale that potentially inhibit cathepsin K, a critical enzyme that caused...